Irwin Naturals Inc. IWINF IWIN FRA: Revenue in Q 3 2022 decreased 7% to $22 million, compared to $23.7 million in Q 3 2021.
EBITDA decreased 33.3% to $1 million from $1.6 million in Q 3 2021, a decline of 33.3%.
In Q 3, Irwin Naturals moved close to becoming the world's largest chain of dedicated psychedelic mental health clinics, according to Klee Irwin, CEO. On an annualized basis, we are on a path to double our profits from last year based on potential acquisitions in the psychedelic mental. The mental healthcare industry is a 1.5 trillion dollar behemoth in desperate need of a disruptive sea change. Sea change in results from psychedelic treatments is a result of the drastic improvements in the average effectiveness of approximately 17%, with standard treatments having an average effectiveness of approximately 17%. We currently have no meaningful competitors in our rearview mirror and intend to be the world's first chain of clinics in this sector to exceed 100 locations. Irwin Naturals THC Products To Be Available In Mississippi Cannabis Dispensaries